Contribution of Flexig mobile application to assess adherence of patients treated with immunoglobulins in chronic diseases
-
Published:2024-02
Issue:1
Volume:3
Page:100173
-
ISSN:2772-8293
-
Container-title:Journal of Allergy and Clinical Immunology: Global
-
language:en
-
Short-container-title:Journal of Allergy and Clinical Immunology: Global
Author:
Pindi Sala TaylorORCID,
Matondo Masisa Daniel,
Crave Jean Charles,
Belmokhtar Chafke,
LeNy Guillaume,
Situakibanza Hippolyte,
Duracinsky Martin,
Cherin Patrick,
Chassany Olivier
Reference41 articles.
1. Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK, Dorsey M, et al. Update on the use of immunoglobulin in human disease: a review of evidence. J Allergy Clin Immunol 2017139(3 suppl):S1-46.
2. Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route;Gardulf;Biodrugs,2007
3. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency;Busse;J Allergy Clin Immunol,2002
4. Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies;Gardulf;Curr Opin Allergy Clin Immunol,2006
5. Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases;Taylor Pindi Sala;Autoimmun Rev,2018